These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25933184)
1. Effects of local nasal immunotherapy in allergic airway inflammation: Using urea denatured Dermatophagoides pteronyssinus. Yu SJ; Liao EC; Tsai JJ Hum Vaccin Immunother; 2015; 11(4):915-21. PubMed ID: 25933184 [TBL] [Abstract][Full Text] [Related]
2. Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy. Liu YH; Tsai JJ Int Arch Allergy Immunol; 2005 Oct; 138(2):161-8. PubMed ID: 16192741 [TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of Tyrophagus putrescentiae allergy by local nasal immunotherapy using strips of Dermatophagoides pteronyssinus. Liao EC; Tsai JJ J Asthma; 2011 Nov; 48(9):957-64. PubMed ID: 21895564 [TBL] [Abstract][Full Text] [Related]
4. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus. Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124 [TBL] [Abstract][Full Text] [Related]
5. Effect of mite allergenic components on innate immune response: Synergy of protease (Group 1 & 3) and non-protease (Group 2 & 7) allergens. Yin SC; Liao EC; Ye CX; Chang CY; Tsai JJ Immunobiology; 2018; 223(6-7):443-448. PubMed ID: 29398016 [TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636 [TBL] [Abstract][Full Text] [Related]
7. Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment. Martín-Muñoz MF; Pineda F; Muiños T; Fontan M; Nevot S; Bosque M; Jurado Palomo J; Torredemer A; Valdesoiro L; Martinez Cañavate AM; Pedemonte Marco C; Allergol Immunopathol (Madr); 2013; 41(1):4-10. PubMed ID: 22321665 [TBL] [Abstract][Full Text] [Related]
8. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response. Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486 [TBL] [Abstract][Full Text] [Related]
9. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients. Soyyigit S; Guloglu D; Ikinciogullari A; Secil D; Oztuna D; Mungan D; Misirligil Z; Sin BA Ann Allergy Asthma Immunol; 2016 Mar; 116(3):244-251.e2. PubMed ID: 26945497 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of DNA vaccine on allergen-induced allergic airway inflammation in mouse model. Li G; Liu Z; Zhong N; Liao B; Xiong Y Cell Mol Immunol; 2006 Oct; 3(5):379-84. PubMed ID: 17092436 [TBL] [Abstract][Full Text] [Related]
11. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model. Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083 [TBL] [Abstract][Full Text] [Related]
12. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy. Liu Y; Xing Z; Wang J; Geng C Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065 [TBL] [Abstract][Full Text] [Related]
13. An Engineered Hybrid Protein from Martínez D; Munera M; Cantillo JF; Wortmann J; Zakzuk J; Keller W; Caraballo L; Puerta L Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234267 [TBL] [Abstract][Full Text] [Related]
14. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions. Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy. Lou W; Wang C; Wang Y; Han D; Zhang L Int Arch Allergy Immunol; 2012; 159(4):391-8. PubMed ID: 22846686 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Hisbergues M; Magi M; Rigaux P; Steuve J; Garcia L; Goudercourt D; Pot B; Pestel J; Jacquet A Clin Exp Allergy; 2007 Sep; 37(9):1286-95. PubMed ID: 17845408 [TBL] [Abstract][Full Text] [Related]
18. Aggravation of airway inflammation and hyper-responsiveness following nasal challenge with Dermatophagoides pteronyssinus in perennial allergic rhinitis without symptoms of asthma. Wang W; Xian M; Xie Y; Zheng J; Li J Allergy; 2016 Mar; 71(3):378-86. PubMed ID: 26595454 [TBL] [Abstract][Full Text] [Related]
19. Recombinant T-cell epitope conjugation: A new approach for Dermatophagoides hypoallergen design. Fernandes AMS; da Silva ES; Silveira EF; Belitardo EMMA; Santiago LF; Silva RC; Dos Santos Alves V; Carneiro DM; Ferreira F; Jacquet A; Pacheco LGC; Alcantara-Neves NM; Pinheiro CS Clin Exp Allergy; 2023 Feb; 53(2):198-209. PubMed ID: 36176209 [TBL] [Abstract][Full Text] [Related]
20. Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Strong P; Clark H; Reid K Clin Exp Allergy; 2002 Dec; 32(12):1794-800. PubMed ID: 12653174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]